Title: Stricken language would be deleted from and underlined language would be added to present law.
Official Title: Stricken language would be deleted from and underlined language would be added to present law.
Number of Sections: 1
Source: versions - HB 1013
Media Type: application/pdf
Strikethrough Detection: 5 sections found

================================================================================

Section 1:
1 State of Arkansas As Engrossed: H1/16/25
A Bill
2 95th General Assembly
3 Regular Session, 2025 HOUSE BILL 1013
4
5 Representatives Hudson, A. Collins, D. Garner, Springer
6
7
For An Act To Be Entitled
8
9 AN ACT TO PROTECT FERTILITY TREATMENT RIGHTS IN THIS
10 STATE; TO PROMOTE THE RIGHT AND ABILITY TO CHOOSE TO
11 RECEIVE FERTILITY TREATMENT PROVIDED IN ACCORDANCE
12 WITH WIDELY ACCEPTED AND EVIDENCE-BASED MEDICAL
13 STANDARDS OF CARE; AND FOR OTHER PURPOSES.
14
15
Subtitle
16
17 TO PROTECT FERTILITY TREATMENT RIGHTS IN
18 THIS STATE.
19
20 BE IT ENACTED BY THE GENERAL ASSEMBLY OF THE STATE OF ARKANSAS:
21
22 SECTION 1. Arkansas Code Title 20, Chapter 9, is amended to add an
23 additional subchapter to read as follows:
24 Subchapter 16 — Fertility Treatment Rights
25
26 20-9-1601. Definitions.
27 As used in this subchapter:
28 (1) "Fertility treatment" means:
29 (A) Preservation of human oocytes, sperm, or embryos for
30 later reproductive use;
31 (B) Artificial insemination, including intravaginal
32 insemination, intracervical insemination, and intrauterine insemination;
33 (C) Assisted reproductive technology, including in vitro
34 fertilization and other treatments or procedures in which reproductive
35 genetic material, such as oocytes, sperm, fertilized eggs, and embryos are
36 handled, when clinically appropriate;
*JMB039*
01-16-2025 15:33:07 JMB039
As Engrossed: H1/16/25 HB1013
1 (D) Genetic testing of embryos;
2 (E) Medications prescribed or obtained over-the-counter,
3 as indicated for fertility;
4 (F) Gamete donation; and
5 (G) Such other information, referrals, treatments,
6 procedures, medications, laboratory testing, technologies, and services
7 relating to fertility as deemed appropriate by the Secretary of the United
8 States Department of Health and Human Services;
9 (2) "Healthcare provider" means an entity or individual that:
10 (A) Is engaged or seeks to engage in the delivery of
11 fertility treatment, including through evidence-based information,
12 counseling, referrals, or items and services relating to, aiding in, or
13 providing fertility treatment; and
14 (B) Is licensed, certified, permitted, or otherwise
15 authorized by the state to engage in the delivery of services relating to,
16 aiding in, or providing fertility treatment;
17 (3)(A) "Healthcare insurer" means an insurance company,
18 insurance service, or insurance organization, including a health maintenance
19 organization, which is licensed to engage in the business of insurance in
20 this state.
21 (B) "Healthcare insurer" does not include a group health
22 plan as defined by 42 U.S.C. § 300gg-91, as existing on January 1, 2025;
23 (4) "Manufacturer" means manufacturer of a drug or device
24 approved, cleared, authorized, or licensed under the Federal Food, Drug, and
25 Cosmetic Act, as existing on January 1, 2025, or 42 U.S.C. § 262, as existing
26 on January 1, 2025, or otherwise legally marketed; and
27 (5) “Widely accepted and evidence-based medical standards of
28 care” means medical services, procedures, and practices that are in
29 accordance with the guidelines of the American Society for Reproductive
30 Medicine.
31
32 20-9-1602. Individual fertility treatment rights.
33 An individual has a right without prohibition, limitation,
34 interference, or impediment to:
35 (1) Receive fertility treatment from a healthcare provider, in
36 accordance with widely accepted and evidence-based medical standards of care;
2 01-16-2025 15:33:07 JMB039
As Engrossed: H1/16/25 HB1013
1 (2) Continue or complete an ongoing fertility treatment
2 previously initiated by a healthcare provider, in accordance with widely
3 accepted and evidence-based medical standards of care;
4 (3) Make decisions and arrangements regarding the donation,
5 testing, use, storage, or disposition of reproductive genetic material, such
6 as oocytes, sperm, fertilized eggs, and embryos; and
7 (4) Establish contractual agreements with a healthcare provider
8 relating to the healthcare provider’s services in handling, testing, storing,
9 shipping, and disposing of the individual’s reproductive genetic material in
10 accordance with widely accepted and evidence-based medical standards of care.
11
12 20-9-1603. Healthcare provider rights.
13 A healthcare provider has a right without prohibition, limitation,
14 interference, or impediment to:
15 (1) Provide or assist with fertility treatment provided in
16 accordance with widely accepted and evidence-based medical standards of care;
17 (2) Continue, complete, or assist with fertility treatment that
18 was lawful when commenced and is provided in accordance with widely accepted
19 and evidence-based medical standards of care;
20 (3) Provide for or assist with the testing, use, storage, or
21 disposition of reproductive genetic material, such as oocytes, sperm,
22 fertilized eggs, and embryos, in accordance with widely accepted and
23 evidence-based medical standards of care; and
24 (4) Establish contractual agreements with individuals or
25 manufacturers relating to the healthcare provider’s services in handling,
26 testing, storing, shipping, and disposing of an individual’s reproductive
27 genetic material.
28
29 20-9-1604. Healthcare insurer rights.
30 A healthcare insurer has a right without prohibition, limitation,
31 interference, or impediment to cover fertility treatment provided in
32 accordance with widely accepted and evidence-based medical standards of care.
33
34 20-9-1605. Manufacturer rights
35 A manufacturer has a right without prohibition, limitation,
36 interference, or impediment to manufacture, import, market, sell, and
3 01-16-2025 15:33:07 JMB039
As Engrossed: H1/16/25 HB1013
1 distribute a drug or device legally marketed and intended for use in
2 providing fertility treatment, including the storage or transport of oocytes,
3 gametes, fertilized eggs, and embryos.
4
5 20-9-1606. Regulation of medicine.
6 The enforcement of state laws regarding medical facilities or
7 healthcare providers does not constitute a violation of this subchapter if:
8 (1) The state laws or rules are in accordance with widely
9 accepted and evidence-based medical standards of care for providing fertility
10 treatment; and
11 (2) The safety or health objective cannot be advanced by a
12 different means that does not prohibit, limit, interfere with, or impede the
13 rights described in this subchapter.
14
15 20-9-1607. Enforcement.
16 (a) An individual or entity adversely affected by an alleged violation
17 of this subchapter may commence a civil action against an individual,
18 employee, official, agency head, contractor, organization, or instrumentality
19 that enacts, implements, or enforces a limitation or requirement that
20 prohibits, limits, interferes with, or impedes the rights of an individual, a
21 healthcare provider, a healthcare insurer, or a manufacturer under this
22 subchapter.
23 (b) A healthcare provider may commence a civil action for relief on
24 behalf of the healthcare provider, the healthcare provider’s staff, or the
25 healthcare provider’s patients who are or may be adversely affected by an
26 alleged violation of this subchapter.
27 (c) In any action under this subchapter, the court may award
28 appropriate equitable relief, including temporary, preliminary, or permanent
29 injunctive relief.
30 (d)(1) In any action under this subchapter, the court shall award
31 costs of litigation, as well as reasonable attorney’s fees, to any prevailing
32 plaintiff.
33 (2) A plaintiff is not liable to a defendant for costs or
34 attorney’s fees in any non-frivolous action under this subchapter unless the
35 costs or attorney’s fees are imposed by the court as part of sanctions for
36 violations committed during the discovery process.
4 01-16-2025 15:33:07 JMB039
As Engrossed: H1/16/25 HB1013
1
2 /s/Hudson
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
5 01-16-2025 15:33:07 JMB039
[DELETED:  A       A S R W S   T T  B   S a S   2  A   (    ( l    ( i    ( f g h]
[DELETED:  H2 0    (    ( a    (    ( p r S   (    ( f c p    ( a a   ( i o t    ( p   ( a C o   ( c a M   2  A i   ( a]
[DELETED:  H3 0   ( p a   ( t a   ( r s a   2  A i   ( a   ( w a   ( d f e   ( m t g   2  A i a   2  A i]
[DELETED:  H4 0 d p g   2  T h   ( a t   ( d r   2  ( o e t p h s  ( b h a  ( a i  ( c p   ( a c v]
[DELETED:  H5 0  /                                  ]


================================================================================

Raw Text:
Stricken language would be deleted from and underlined language would be added to present law.
1 State of Arkansas As Engrossed: H1/16/25
A Bill
2 95th General Assembly
3 Regular Session, 2025 HOUSE BILL 1013
4
5 Representatives Hudson, A. Collins, D. Garner, Springer
6
7
For An Act To Be Entitled
8
9 AN ACT TO PROTECT FERTILITY TREATMENT RIGHTS IN THIS
10 STATE; TO PROMOTE THE RIGHT AND ABILITY TO CHOOSE TO
11 RECEIVE FERTILITY TREATMENT PROVIDED IN ACCORDANCE
12 WITH WIDELY ACCEPTED AND EVIDENCE-BASED MEDICAL
13 STANDARDS OF CARE; AND FOR OTHER PURPOSES.
14
15
Subtitle
16
17 TO PROTECT FERTILITY TREATMENT RIGHTS IN
18 THIS STATE.
19
20 BE IT ENACTED BY THE GENERAL ASSEMBLY OF THE STATE OF ARKANSAS:
21
22 SECTION 1. Arkansas Code Title 20, Chapter 9, is amended to add an
23 additional subchapter to read as follows:
24 Subchapter 16 — Fertility Treatment Rights
25
26 20-9-1601. Definitions.
27 As used in this subchapter:
28 (1) "Fertility treatment" means:
29 (A) Preservation of human oocytes, sperm, or embryos for
30 later reproductive use;
31 (B) Artificial insemination, including intravaginal
32 insemination, intracervical insemination, and intrauterine insemination;
33 (C) Assisted reproductive technology, including in vitro
34 fertilization and other treatments or procedures in which reproductive
35 genetic material, such as oocytes, sperm, fertilized eggs, and embryos are
36 handled, when clinically appropriate;
*JMB039*
01-16-2025 15:33:07 JMB039

As Engrossed: H1/16/25 HB1013
1 (D) Genetic testing of embryos;
2 (E) Medications prescribed or obtained over-the-counter,
3 as indicated for fertility;
4 (F) Gamete donation; and
5 (G) Such other information, referrals, treatments,
6 procedures, medications, laboratory testing, technologies, and services
7 relating to fertility as deemed appropriate by the Secretary of the United
8 States Department of Health and Human Services;
9 (2) "Healthcare provider" means an entity or individual that:
10 (A) Is engaged or seeks to engage in the delivery of
11 fertility treatment, including through evidence-based information,
12 counseling, referrals, or items and services relating to, aiding in, or
13 providing fertility treatment; and
14 (B) Is licensed, certified, permitted, or otherwise
15 authorized by the state to engage in the delivery of services relating to,
16 aiding in, or providing fertility treatment;
17 (3)(A) "Healthcare insurer" means an insurance company,
18 insurance service, or insurance organization, including a health maintenance
19 organization, which is licensed to engage in the business of insurance in
20 this state.
21 (B) "Healthcare insurer" does not include a group health
22 plan as defined by 42 U.S.C. § 300gg-91, as existing on January 1, 2025;
23 (4) "Manufacturer" means manufacturer of a drug or device
24 approved, cleared, authorized, or licensed under the Federal Food, Drug, and
25 Cosmetic Act, as existing on January 1, 2025, or 42 U.S.C. § 262, as existing
26 on January 1, 2025, or otherwise legally marketed; and
27 (5) “Widely accepted and evidence-based medical standards of
28 care” means medical services, procedures, and practices that are in
29 accordance with the guidelines of the American Society for Reproductive
30 Medicine.
31
32 20-9-1602. Individual fertility treatment rights.
33 An individual has a right without prohibition, limitation,
34 interference, or impediment to:
35 (1) Receive fertility treatment from a healthcare provider, in
36 accordance with widely accepted and evidence-based medical standards of care;
2 01-16-2025 15:33:07 JMB039

As Engrossed: H1/16/25 HB1013
1 (2) Continue or complete an ongoing fertility treatment
2 previously initiated by a healthcare provider, in accordance with widely
3 accepted and evidence-based medical standards of care;
4 (3) Make decisions and arrangements regarding the donation,
5 testing, use, storage, or disposition of reproductive genetic material, such
6 as oocytes, sperm, fertilized eggs, and embryos; and
7 (4) Establish contractual agreements with a healthcare provider
8 relating to the healthcare provider’s services in handling, testing, storing,
9 shipping, and disposing of the individual’s reproductive genetic material in
10 accordance with widely accepted and evidence-based medical standards of care.
11
12 20-9-1603. Healthcare provider rights.
13 A healthcare provider has a right without prohibition, limitation,
14 interference, or impediment to:
15 (1) Provide or assist with fertility treatment provided in
16 accordance with widely accepted and evidence-based medical standards of care;
17 (2) Continue, complete, or assist with fertility treatment that
18 was lawful when commenced and is provided in accordance with widely accepted
19 and evidence-based medical standards of care;
20 (3) Provide for or assist with the testing, use, storage, or
21 disposition of reproductive genetic material, such as oocytes, sperm,
22 fertilized eggs, and embryos, in accordance with widely accepted and
23 evidence-based medical standards of care; and
24 (4) Establish contractual agreements with individuals or
25 manufacturers relating to the healthcare provider’s services in handling,
26 testing, storing, shipping, and disposing of an individual’s reproductive
27 genetic material.
28
29 20-9-1604. Healthcare insurer rights.
30 A healthcare insurer has a right without prohibition, limitation,
31 interference, or impediment to cover fertility treatment provided in
32 accordance with widely accepted and evidence-based medical standards of care.
33
34 20-9-1605. Manufacturer rights
35 A manufacturer has a right without prohibition, limitation,
36 interference, or impediment to manufacture, import, market, sell, and
3 01-16-2025 15:33:07 JMB039

As Engrossed: H1/16/25 HB1013
1 distribute a drug or device legally marketed and intended for use in
2 providing fertility treatment, including the storage or transport of oocytes,
3 gametes, fertilized eggs, and embryos.
4
5 20-9-1606. Regulation of medicine.
6 The enforcement of state laws regarding medical facilities or
7 healthcare providers does not constitute a violation of this subchapter if:
8 (1) The state laws or rules are in accordance with widely
9 accepted and evidence-based medical standards of care for providing fertility
10 treatment; and
11 (2) The safety or health objective cannot be advanced by a
12 different means that does not prohibit, limit, interfere with, or impede the
13 rights described in this subchapter.
14
15 20-9-1607. Enforcement.
16 (a) An individual or entity adversely affected by an alleged violation
17 of this subchapter may commence a civil action against an individual,
18 employee, official, agency head, contractor, organization, or instrumentality
19 that enacts, implements, or enforces a limitation or requirement that
20 prohibits, limits, interferes with, or impedes the rights of an individual, a
21 healthcare provider, a healthcare insurer, or a manufacturer under this
22 subchapter.
23 (b) A healthcare provider may commence a civil action for relief on
24 behalf of the healthcare provider, the healthcare provider’s staff, or the
25 healthcare provider’s patients who are or may be adversely affected by an
26 alleged violation of this subchapter.
27 (c) In any action under this subchapter, the court may award
28 appropriate equitable relief, including temporary, preliminary, or permanent
29 injunctive relief.
30 (d)(1) In any action under this subchapter, the court shall award
31 costs of litigation, as well as reasonable attorney’s fees, to any prevailing
32 plaintiff.
33 (2) A plaintiff is not liable to a defendant for costs or
34 attorney’s fees in any non-frivolous action under this subchapter unless the
35 costs or attorney’s fees are imposed by the court as part of sanctions for
36 violations committed during the discovery process.
4 01-16-2025 15:33:07 JMB039

As Engrossed: H1/16/25 HB1013
1
2 /s/Hudson
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
5 01-16-2025 15:33:07 JMB039

[DELETED:  A       A S R W S   T T  B   S a S   2  A   (    ( l    ( i    ( f g h]
[DELETED:  H2 0    (    ( a    (    ( p r S   (    ( f c p    ( a a   ( i o t    ( p   ( a C o   ( c a M   2  A i   ( a]
[DELETED:  H3 0   ( p a   ( t a   ( r s a   2  A i   ( a   ( w a   ( d f e   ( m t g   2  A i a   2  A i]
[DELETED:  H4 0 d p g   2  T h   ( a t   ( d r   2  ( o e t p h s  ( b h a  ( a i  ( c p   ( a c v]
[DELETED:  H5 0  /                                  ]